Stocklytics Platform
Asset logo for symbol BLFS
BioLife Solutions
BLFS54
$20.72arrow_drop_down1.19%-$0.25
Asset logo for symbol BLFS
BLFS54

$20.72

arrow_drop_down1.19%

Income Statement (BLFS)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
EBIT-$9.89M-$13.57M-$14.63M-$15.80M-$12.88M
EBITDA-$7.61M-$11.18M-$11.35M-$14.35M-$11.03M
gross Profit$11.64M$8.33M$11.64M$11.81M$14.03M
NET Income-$10.22M-$13.38M-$29.13M-$10.19M-$13.71M
total Revenue$31.72M$32.73M$33.32M$39.50M$37.70M

Balance Sheet (BLFS)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt$11.23M$7.25M$24.96M$23.16M$24.11M
stockholders Equity$333.40M$337.66M$332.01M-$270.82M-$260.62M
total Assets$401.60M$412.71M$411.15M$433.17M$446.47M
total Debt$40.96M$42.69M$44.20M$44.56M$43.21M
total Liabilities$68.19M$75.05M$79.13M$81.04M$88.36M

Cash Flow (BLFS)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow-$952.00K$9.84M$608.00K$704.00K-$562.00K
free Cash Flow-$4.83M$1.33M-$5.87M-$8.32M-$6.00M
investing Cash Flow---$9.29M$2.92M
operating Cash Flow-$4.47M$2.31M-$4.37M-$7.71M-$2.71M

BioLife Solutions (BLFS) Financials

BioLife Solutions Inc (BLFS) is a leading provider of biopreservation tools and services for cell and gene therapy, regenerative medicine, and other biotech applications. The company's innovative products enable the long-term preservation and storage of cells, tissues, and organs, ensuring their viability and functionality for use in medical research and treatments.

The income statement of BioLife Solutions Inc (BLFS) provides valuable insights into the financial performance of the company. It shows the revenue generated by the company, its operating expenses, and the net income derived from the stockholders' investment. This information helps investors and analysts assess the profitability and efficiency of the company's operations.

EBIT, or Earnings Before Interest and Taxes, is a measure of a company's operating profit. It reveals the profitability of a company's core operations, excluding interest expenses and taxes. EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, further removes non-cash expenses like depreciation and amortization from the profitability equation. This provides a clearer picture of the company's cash generation ability.

Gross profit is the revenue obtained after deducting the cost of goods sold. It is a useful indicator of a company's profitability before considering other operating expenses. Net income from stockholders represents the final profit after accounting for all expenses, including interest, taxes, and non-operating items. This metric gives a comprehensive view of the overall financial performance of BioLife Solutions Inc (BLFS).

Total revenue is the sum of all the income generated by the company. It includes revenue from sales, services, and any other sources. This metric gives an overview of the company's overall financial performance. By analyzing the balance sheet of BioLife Solutions Inc (BLFS), investors and analysts can understand the company's financial position at a specific point in time.

Cash equivalents refer to highly liquid assets that can be quickly converted into cash. These include treasury bills, money market funds, and short-term government bonds. Net debt represents the company's total debt minus its cash and cash equivalents. It indicates the company's ability to repay its debts using its available liquid resources.

Stockholders' equity represents the residual interest in the company's assets after deducting liabilities. It is the excess of a company's assets over its liabilities and reflects the shareholders' investment in the business. Total assets are the sum of all the company's possessions, including cash, investments, property, and equipment. Total debt and total liabilities represent the obligations and debts owed by the company to various parties.

Cash flow is the measure of cash generated or used by the company during a specific period. It includes cash flows from operations, investing, and financing activities. Financing cash flow refers to the cash used in or generated from activities like issuing or repurchasing of shares, payment of dividends, and debt repayments. Free cash flow represents the cash flow available to the company after deducting capital expenditures required to maintain its current operations.

Investing cash flow reflects the cash flow related to investments in property, plant, equipment, and other assets. It includes the purchase and sale of these assets. Operating cash flow measures the cash generated from the company's core operations, excluding investing and financing activities. It provides insights into the company's ability to generate cash from its everyday operations.

add BioLife Solutions  to watchlist

Keep an eye on BioLife Solutions

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level